Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1134

1.

Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.

Stangl-Kremser J, Mari A, Suarez-Ibarrola R, D'Andrea D, Korn SM, Pones M, Kramer G, Karakiewicz P, Enikeev DV, Glybochko PV, Briganti A, Shariat SF.

Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30478-8. doi: 10.1016/j.urolonc.2019.11.005. [Epub ahead of print]

PMID:
31953003
2.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy.

Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Tian Z, Larcher A, Capitanio U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A, Karakiewicz PI.

J Surg Oncol. 2020 Jan 12. doi: 10.1002/jso.25840. [Epub ahead of print]

PMID:
31930511
3.

Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy.

Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.

J Natl Compr Canc Netw. 2020 Jan;18(1):44-51. doi: 10.6004/jnccn.2019.7350.

PMID:
31910387
4.

Epigenetic alterations of testicular germ cell tumours.

Ilijazi D, Shariat SF, Hassler MR, Lemberger U, Ertl IE.

Curr Opin Urol. 2020 Jan 3. doi: 10.1097/MOU.0000000000000724. [Epub ahead of print]

PMID:
31905176
5.

Efficacy of Preoperative Chemotherapy in High-Risk Upper Tract Urothelial Carcinoma (UTUC).

Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF; UTUC collaboration.

J Urol. 2020 Jan 2:101097JU0000000000000737. doi: 10.1097/JU.0000000000000737. [Epub ahead of print]

PMID:
31898919
6.

Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Kimura S, Iwata T, Abufaraj M, Janisch F, D'Andrea D, Moschini M, Al-Rawashdeh B, Fajkovic H, Seebacher V, Egawa S, Shariat SF.

Clin Genitourin Cancer. 2019 Dec 5. pii: S1558-7673(19)30358-1. doi: 10.1016/j.clgc.2019.11.007. [Epub ahead of print] Review.

PMID:
31889669
7.

PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.

Yeh HC, Margulis V, Singla N, Hernandez E, Panwar V, Woldu SL, Karam JA, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Li CC, Ke HL, Li WM, Lee HY, Rapoport LM, Lotan Y, Kapur P, Shariat SF, Hsieh JT, Wu WJ.

Urol Oncol. 2019 Dec 17. pii: S1078-1439(19)30483-1. doi: 10.1016/j.urolonc.2019.11.010. [Epub ahead of print]

PMID:
31862213
8.

4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.

Beer L, Polanec SH, Baltzer PAT, Schatzl G, Georg D, Schestak C, Dutschke A, Herrmann H, Mazal P, Brendel AK, Shariat SF, Ringl H, Helbich TH, Apfaltrer P.

PLoS One. 2019 Dec 19;14(12):e0225673. doi: 10.1371/journal.pone.0225673. eCollection 2019.

9.

Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients.

Vartolomei L, Vartolomei MD, Shariat SF.

Eur Urol Focus. 2019 Dec 10. pii: S2405-4569(19)30330-X. doi: 10.1016/j.euf.2019.10.008. [Epub ahead of print] Review.

PMID:
31836463
10.

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.

Martini A, Fossati N, Karnes RJ, Boorjian SA, Boeri L, Bossi A, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Robesti D, Bartkowiak D, Böhmer D, Shariat SF, Goldner G, Battaglia A, Joniau S, Berghen C, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A.

Eur Urol Oncol. 2019 Dec 3. pii: S2588-9311(19)30162-2. doi: 10.1016/j.euo.2019.11.003. [Epub ahead of print]

PMID:
31810893
11.

Second line immune checkpoint inhibition in urothelial cancer.

Gust KM, Abufaraj M, D'Andrea D, Moschini M, Soria F, Shariat SF.

Transl Androl Urol. 2019 Oct;8(5):414-420. doi: 10.21037/tau.2019.09.18. No abstract available.

12.

Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.

Kimura S, D'Andrea D, Iwata T, Foerster B, Janisch F, Parizi MK, Moschini M, Briganti A, Babjuk M, Chlosta P, Karakiewicz PI, Enikeev D, Rapoport LM, Seebacher V, Egawa S, Abufaraj M, Shariat SF.

World J Urol. 2019 Dec 4. doi: 10.1007/s00345-019-03038-5. [Epub ahead of print]

PMID:
31797075
13.

Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy.

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Marchioni M, Tian Z, Saad F, Taussky D, Briganti A, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Can Urol Assoc J. 2019 Nov 29. doi: 10.5489/cuaj.6087. [Epub ahead of print]

PMID:
31793866
14.

Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis.

Jubber I, Shariat SF, Conroy S, Tan WS, Gordon PC, Lotan Y, Messing EM, Stenzl A, Rhijn BV, Kelly JD, Catto JWF, Cumberbatch MG.

Eur Urol. 2019 Nov 29. pii: S0302-2838(19)30776-6. doi: 10.1016/j.eururo.2019.10.010. [Epub ahead of print] Review.

PMID:
31791622
15.

Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.

D'Andrea D, Soria F, Abufaraj M, Pones M, Gontero P, Machado AT, Waksman R, Enikeev DV, Glybochko PV, Adonias SP, Nahas WC, Shariat SF, Chade DC.

Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30325-8. doi: 10.1016/j.clgc.2019.10.021. [Epub ahead of print]

PMID:
31786120
16.

Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis.

Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Enikeev DV, Kimura S, Egawa S, Shariat SF.

Int J Clin Oncol. 2019 Nov 25. doi: 10.1007/s10147-019-01578-9. [Epub ahead of print] Review.

PMID:
31768692
17.

Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.

Rosiello G, Palumbo C, Knipper S, Pecoraro A, Dzyuba-Negrean C, Luzzago S, Tian Z, Gallina A, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30442-9. doi: 10.1016/j.urolonc.2019.10.018. [Epub ahead of print]

PMID:
31761614
18.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19.

PMID:
31753752
19.

[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)].

Lebentrau S, Wolff I, Hempel MC, Haccius M, Kluth LA, Pycha A, Brookman-May S, Schneider TR, Hermanns T, Distler FA, Boegemann M, Kübler H, Shariat SF, Burger M, May M.

Aktuelle Urol. 2019 Nov 19. doi: 10.1055/a-1032-8086. [Epub ahead of print] German.

PMID:
31745963
20.

Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.

Stangl-Kremser J, Suarez-Ibarrola R, Andrea D, Korn SM, Pones M, Kramer G, Marhold M, Krainer M, Enikeev DV, Glybochko PV, Tamandl D, Shariat SF, Baltzer P.

Prostate Cancer Prostatic Dis. 2019 Nov 19. doi: 10.1038/s41391-019-0186-6. [Epub ahead of print]

PMID:
31745255
21.

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari B, Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA.

Ann Oncol. 2019 Nov 1;30(11):1697-1727. doi: 10.1093/annonc/mdz296.

PMID:
31740927
22.

The changing role of lasers in urologic surgery.

Enikeev D, Shariat SF, Taratkin M, Glybochko P.

Curr Opin Urol. 2020 Jan;30(1):24-29. doi: 10.1097/MOU.0000000000000695.

PMID:
31724998
23.

En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.

Mori K, D'Andrea D, Enikeev DV, Egawa S, Shariat SF.

Curr Opin Urol. 2020 Jan;30(1):41-47. doi: 10.1097/MOU.0000000000000697.

PMID:
31724997
24.

Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.

Rosiello G, Knipper S, Palumbo C, Pecoraro A, Luzzago S, Deuker M, Tian Z, Gandaglia G, Gallina A, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30316-7. doi: 10.1016/j.clgc.2019.10.012. [Epub ahead of print]

PMID:
31711842
25.

Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes.

Mistretta FA, Cyr SJ, Palumbo C, Mazzone E, Knipper S, Tian Z, Nazzani S, Montanari E, Tilki D, Briganti A, Shariat SF, Perrotte P, Saad F, de Cobelli O, Karakiewicz PI.

Clin Oncol (R Coll Radiol). 2019 Nov 6. pii: S0936-6555(19)30448-0. doi: 10.1016/j.clon.2019.10.001. [Epub ahead of print]

PMID:
31706712
26.

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

Hentschel AE, van Rhijn BWG, Bründl J, Compérat EM, Plass K, Rodríguez O, Henríquez JDS, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Scavarda-Lamberti A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Cohen D, Lunelli L, Cussenot O, Sheikh SE, Volanis D, Coté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Babjuk M, van der Kwast TH, Sylvester RJ.

Urol Oncol. 2019 Nov 5. pii: S1078-1439(19)30401-6. doi: 10.1016/j.urolonc.2019.10.002. [Epub ahead of print]

PMID:
31704141
27.

Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.

Mazzone E, Knipper S, Mistretta FA, Palumbo C, Tian Z, Gallina A, Tilki D, Shariat SF, Montorsi F, Saad F, Briganti A, Karakiewicz PI.

J Natl Compr Canc Netw. 2019 Nov 1;17(11):1344-1352. doi: 10.6004/jnccn.2019.7319.

PMID:
31693981
28.

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.

Gontero P, Pisano F, Palou J, Joniau S, Albersen M, Colombo R, Briganti A, Pellucchi F, Faba OR, van Rhijn BW, van de Putte EF, Babjuk M, Fritsche HM, Mayr R, Albers P, Niegisch G, Anract J, Masson-Lecomte A, De la Taille A, Roupret M, Peyronnet B, Cai T, Witjes AJ, Bruins M, Baniel J, Mano R, Lapini A, Sessa F, Irani J, Brausi M, Stenzl A, Karnes JR, Scherr D, O'Malley P, Taylor B, Shariat SF, Black P, Abdi H, Matveev VB, Samuseva O, Parekh D, Gonzalgo M, Vetterlein MW, Aziz A, Fisch M, Catto J, Pang KH, Xylinas E, Rink M; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.

World J Urol. 2019 Nov 6. doi: 10.1007/s00345-019-02982-6. [Epub ahead of print]

PMID:
31691084
29.

Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI?

Polanec SH, Bickel H, Wengert GJ, Arnoldner M, Clauser P, Susani M, Shariat SF, Pinker K, Helbich TH, Baltzer PAT.

Clin Radiol. 2020 Feb;75(2):157.e1-157.e7. doi: 10.1016/j.crad.2019.09.139. Epub 2019 Nov 2.

PMID:
31690449
30.

Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies.

Mazzone E, Mistretta FA, Knipper S, Tian Z, Palumbo C, Gandaglia G, Fossati N, Shariat SF, Saad F, Montorsi F, Graefen M, Briganti A, Karakiewicz PI.

Prostate Cancer Prostatic Dis. 2019 Nov 4. doi: 10.1038/s41391-019-0183-9. [Epub ahead of print]

PMID:
31685982
31.

Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy.

Palumbo C, Knipper S, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

Surg Oncol. 2019 Oct 25;32:8-13. doi: 10.1016/j.suronc.2019.10.014. [Epub ahead of print]

PMID:
31683158
32.

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.

Black AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Sridhar SS, Black PC.

Urol Oncol. 2020 Jan;38(1):3.e17-3.e27. doi: 10.1016/j.urolonc.2019.09.023. Epub 2019 Oct 31.

PMID:
31676278
33.

Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis.

Hassler MR, Abufaraj M, Kimura S, Stangl-Kremser J, Gust K, Glybochko PV, Schmidinger M, Karakiewicz PI, Shariat SF.

Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30273-3. doi: 10.1016/j.clgc.2019.09.004. [Epub ahead of print] Review.

PMID:
31668768
34.

Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary.

Stangl-Kremser J, Kramer G, Shariat SF.

Clin Genitourin Cancer. 2019 Dec;17(6):e1188-e1192. doi: 10.1016/j.clgc.2019.08.001. Epub 2019 Aug 20.

PMID:
31623929
35.

Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.

Grubmüller B, Rasul S, Baltzer P, Fajkovic H, D'Andrea D, Berndl F, Maj-Hes A, Grubmüller KH, Mitterhauser M, Wadsak W, Pfaff S, Shariat SF, Hacker M, Kramer G, Hartenbach M.

Prostate. 2020 Jan;80(1):74-82. doi: 10.1002/pros.23919. Epub 2019 Oct 15.

PMID:
31614001
36.
37.

Comprehensive analysis of in-hospital delirium after major surgical oncology procedures.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Graefen M, Montorsi F, Saad F, Shariat SF, Schips L, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2019 Sep 27. doi: 10.5489/cuaj.6030. [Epub ahead of print]

PMID:
31599720
38.

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.

Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K.

Eur Urol Oncol. 2019 Oct 4. pii: S2588-9311(19)30145-2. doi: 10.1016/j.euo.2019.09.004. [Epub ahead of print]

PMID:
31591037
39.

TEMPORARY REMOVAL: Quality Indicators for Bladder Cancer Services: A Collaborative Review.

Leow JJ, Catto JWF, Efstathiou JA, Gore JL, Hussein AA, Shariat SF, Smith AB, Weizer AZ, Wirth M, Witjes JA, Trinh QD.

Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30690-6. doi: 10.1016/j.eururo.2019.09.001. [Epub ahead of print]

PMID:
31563501
40.

The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.

Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Tian Z, Shariat SF, Saad F, de Cobelli O, Karakiewicz PI.

J Surg Oncol. 2019 Dec;120(7):1266-1275. doi: 10.1002/jso.25717. Epub 2019 Sep 28.

PMID:
31562831
41.

Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Mori K, Kimura S, Parizi MK, Enikeev DV, Glybochko PV, Seebacher V, Fajkovic H, Mostafaei H, Lysenko I, Janisch F, Egawa S, Shariat SF.

Clin Genitourin Cancer. 2019 Dec;17(6):409-418. doi: 10.1016/j.clgc.2019.07.009. Epub 2019 Jul 19. Review.

PMID:
31558410
42.

Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer.

Huebner NA, Shariat SF.

Eur Urol. 2020 Jan;77(1):132-133. doi: 10.1016/j.eururo.2019.08.029. Epub 2019 Sep 19. No abstract available.

PMID:
31542306
43.

Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?

Janisch F, Yu H, Vetterlein MW, Dahlem R, Engel O, Fisch M, Shariat SF, Soave A, Rink M.

J Clin Med. 2019 Sep 13;8(9). pii: E1459. doi: 10.3390/jcm8091459.

44.

What Is the Significance of Variant Histology in Urothelial Carcinoma?

Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA 3rd, Roupret M, Kamat AM.

Eur Urol Focus. 2019 Sep 15. pii: S2405-4569(19)30278-0. doi: 10.1016/j.euf.2019.09.003. [Epub ahead of print] Review.

PMID:
31530497
45.

Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?

Soria F, D'Andrea D, Moschini M, Giordano A, Mazzoli S, Pizzuto G, Hurle R, Colombo R, Briganti A, Altieri V, Shariat SF, Gontero P.

Urol Oncol. 2019 Sep 14. pii: S1078-1439(19)30328-X. doi: 10.1016/j.urolonc.2019.08.010. [Epub ahead of print]

PMID:
31526650
46.

Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.

Mazzone E, Mistretta FA, Knipper S, Tian Z, Palumbo C, Gandaglia G, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Dec;17(6):e1153-e1162. doi: 10.1016/j.clgc.2019.08.009. Epub 2019 Aug 21.

PMID:
31515197
47.

Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails.

Moschini M, Shariat SF, Black P, Kamat AM, Stabile A, Cathelineau X, Kassouf W, Bochner BH, Xylinas E, Roupret M, Boorjian SA, Catto JW, Sanchez-Salas R.

Eur Urol. 2020 Jan;77(1):1-2. doi: 10.1016/j.eururo.2019.08.021. Epub 2019 Sep 8.

PMID:
31506227
48.

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.

Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF.

World J Urol. 2019 Sep 6. doi: 10.1007/s00345-019-02936-y. [Epub ahead of print]

PMID:
31493109
49.

Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.

Palumbo C, Mistretta FA, Knipper S, Mazzone E, Pecoraro A, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lavallee LT, Karakiewicz PI.

Minerva Urol Nefrol. 2019 Sep 4. doi: 10.23736/S0393-2249.19.03496-9. [Epub ahead of print]

PMID:
31487976
50.

Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.

Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Kimura S, Enikeev DV, Egawa S, Shariat SF.

J Urol. 2019 Sep 3:101097JU0000000000000523. doi: 10.1097/JU.0000000000000523. [Epub ahead of print]

PMID:
31479406

Supplemental Content

Loading ...
Support Center